Calcium-binding protein S100P and cancer: mechanisms and clinical relevance

  • Hongfei Jiang
  • Hang Hu
  • Xiaomei Tong
  • Qiuhong Jiang
  • Haiyan Zhu
  • Songying Zhang
Review

DOI: 10.1007/s00432-011-1062-5

Cite this article as:
Jiang, H., Hu, H., Tong, X. et al. J Cancer Res Clin Oncol (2012) 138: 1. doi:10.1007/s00432-011-1062-5

Abstract

S100P is a 95-amino-acid protein and a member of the S100 family. It was first purified from placenta. The promoter area of S100P has binding sites for SMAD, STAT/CREB and SP/KLF, key regulatory elements participating in transcriptional activation of the S100P gene. Increased levels of S100P have been observed in multiple tumor cell lines and breast, pancreas, lung and ovary carcinomas. S100P has been shown to mediate tumor growth, metastasis and invasion through the binding of Ca2+ ions, receptor for advanced glycation end products, cytoskeletal protein ezrin, calcyclin-binding protein/Siah-1-interacting protein and cathepsin D. S100P could potentially serve as diagnostic marker, prognostic/predictive indicator and therapy target for different carcinomas.

Keywords

S100P Carcinogenesis Tumor diagnosis 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Hongfei Jiang
    • 1
  • Hang Hu
    • 1
  • Xiaomei Tong
    • 1
  • Qiuhong Jiang
    • 1
  • Haiyan Zhu
    • 1
  • Songying Zhang
    • 1
  1. 1.Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, College of MedicineZhejiang UniversityHangzhouChina

Personalised recommendations